InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
50%
T+90 mean return
+3.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Llorens Josep, Directeur Exécutif. Director active across 2 companies, notably HAEMONETICS CORP. Cumulatively, 17 disclosures have been logged. Split: 0 buy · 8 sells. Total volume traded: €186k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 28 May 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
14,140 shares0Common StockSEC:0001127602-24-016813:0
822 shares@ US$94.8212.8% of flowCommon StockSEC:0001127602-24-016169:0
258 shares@ US$96.494.1% of flowCommon StockSEC:0001127602-24-015868:0
2,391 shares@ US$56.5721.4% of flowCommon StockSEC:0001127602-23-021080:0
1,423 shares@ US$83.3419.6% of flowCommon StockSEC:0001127602-23-016313:0
3,084 sharesCommon StockSEC:0001127602-23-015937:0
113 shares@ US$88.161.6% of flowCommon StockSEC:0001127602-23-015738:0
2,391 shares@ US$56.5722.2% of flowCommon StockSEC:0001127602-23-002187:0
101 shares@ US$73.781.3% of flowCommon StockSEC:0001127602-22-022153:0
1,418 shares@ US$59.100.0030% mcap82.8% of flowCommon StockSEC:0001127602-22-015369:0
107 shares@ US$56.100.0002% mcap6.0% of flowCommon StockSEC:0001127602-22-014988:0
100 shares@ US$64.610.0002% mcap5.7% of flowCommon StockSEC:0000899243-21-035451:0
100 shares@ US$64.6151.0% of flowCommon StockSEC:0000899243-21-035451
3,535 sharesCommon StockSEC:0001127602-21-017681
3,535 sharesCommon StockSEC:0001127602-21-017681:0
114 shares@ US$55.970.0002% mcap5.5% of flowCommon StockSEC:0001127602-21-017271:0
114 shares@ US$55.9749.0% of flowCommon StockSEC:0001127602-21-017271
17 of 17 declarations
About Llorens Josep
Josep Llorens is the Executive Vice President at Haemonetics Corp. He oversees strategic operations and contributes to the financial direction of the company. With significant experience in the medical device sector, Josep is involved in planning and executing growth initiatives.
